Natco Pharma rises 4 percent after filing ANDA for generic lung cancer drug - Business Standard

Read at news.google.com

Published over three months ago View all stories for Natco Pharma | Natco Pharma Hype Analysis

We analyze Natco Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Natco Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Natco Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Natco Pharma stock to make a market-neutral strategy. Peer analysis of Natco Pharma could also be used in its relative valuation, which is a method of valuing Natco Pharma by comparing valuation metrics with similar companies.

When running Natco Pharma's price analysis, check to measure Natco Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Natco Pharma is operating at the current time. Most of Natco Pharma's value examination focuses on studying past and present price action to predict the probability of Natco Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Natco Pharma's price. Additionally, you may evaluate how the addition of Natco Pharma to your portfolios can decrease your overall portfolio volatility.